Clinical Trials Directory

Trials / Completed

CompletedNCT02249780

Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy

The Use of Indocyanine Green Fluorescence to Assses the Vascularisation of the Parathyroid Glands During Thyroid Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
146 (actual)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Evaluate parathyroid gland perfusion during total thyroidectomy or thyroid totalisation surgery. Create an objective basis for the decision whether or not to transplant the parathyroid glands. Avoide postoperative serum calcium and parathyroid hormone dosages, and thus abstention of systematic supplementation with calcium and vitamin D in case of good perfusion.

Detailed description

Parathyroid intraoperative indocyanine green (ICG) angiography is a new concept. To simplify the procedure the investigators have classified images into three categories: ICG 2: good blood supply (the gland has a white color); ICG 1: traumatic gland (the gland has a grayish color) and ICG 0: the gland is not vascularized (she has a black color). The investigators have applied the same criteria for visual values. The investigators will randomize 138 patients with good ICG test values (at least one gland that is visually ≥1 and ICG 2): 69 will be subject to the usual postoperative care in the investigators service: 24 hours monitoring with dosage of calcium and PTH in the morning on postoperative day 1 and routine supplementation with Calcimagon D3 Forte (1g Calcium and 800 IU of 25-OH-vitamin D) BD by mouth until postoperative follow-up appointment, which takes place between day 10 and 15. Depending on the results of blood tests patients will also be given Rocaltrol substitution (1, 25-OH-Vitamin D) 0.5mcg BD. The remaining patients will be monitored 24 hours in hospital looking for clinical signs and symptoms of hypocalcemia but without any blood dosage or systematic supplementation. If signs and / or symptoms of hypocalcemia develop (tingling, muscle spasms, Chvostek sign), a blood test will be performed and patients will be substituted by the usual protocol. All patients will be reviewed at 10 - 15 days of the intervention with the relevant balance sheet.

Conditions

Interventions

TypeNameDescription
PROCEDUREPostoperative parathyroid function testCalcium and parathormone dosage at 24 hours and ten day after surgery
PROCEDURENo postoperative parathyroid dosage and supplementationThe patients will be clinically followed for 24 hours after surgery and caclium and parathormone dosage will be done at ten days after surgery. No supplementation will be given.
PROCEDUREICG parathyroid angiographyInjection of 3,5 mL of indocyanine green intravenously and perform angiography of parathyroid glands after thyroid removal.
DRUGParathyroid supplementationSupplementration with Calcimagon D3 Forte (1gr Calcium and 800 IU of 25-OH-vitamin D) from surgery day to up to 10 days afeter surgery.

Timeline

Start date
2014-09-01
Primary completion
2016-02-01
Completion
2016-02-01
First posted
2014-09-26
Last updated
2016-04-18

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02249780. Inclusion in this directory is not an endorsement.